After years of failure, including some pharmaceutical companies calling off Alzheimer’s research altogether, Biogen offers a glimmer of hope: New data from a Phase…
We tend to think of problems with hearing, eyesight and thinking as just another part of getting older. And to an extent, those functions…
Scientists have long speculated whether a build-up of metals in the brain might trigger Alzheimer’s, a school of thought that dates back to a…
Does the herpes virus play a role in Alzheimer’s development? A new study funded by the National Institutes on Aging and led by several…
For years, hopes have been raised and then dashed in the search for a cure for Alzheimer’s as drugs that pass stage 2 clinical…
A new study released by the University of Montana showed that symptoms of Alzheimer’s disease were present in those who had been exposed to…
Peter Snyder of Lifespan Hospital System discusses retinal imaging’s potential for helping diagnose Alzheimer’s early, even before symptoms appear. What if getting a reliable…
Any Alzheimer’s drug under development has a complicated journey from formulation to clinical trials to potentially getting in the hands of patients. We spoke…
In a mice study, researchers have developed an antibody to clears amyloid plaques, a hallmark of Alzheimer’s. Most scientists believe that Alzheimer’s is caused…
Experimental drugs for Alzheimer’s disease have a 99.6 percent failure rate. Not such a great track record. But, according to an expert in the…
Research finds a link between levels of beta-amyloid in people without Alzheimer’s symptoms, and the age at which their parents begin experiencing symptoms of…
Although some treatments for Alzheimer’s may slow down the onset of symptoms, there is no cure or way to reverse the disease, and the…
Excessive alcohol consumption is a well-researched hazard to your health. But for years, the scientific community has been trying to figure out if small…
Another Alzheimer’s drug has failed in a phase 3 trial, the stage right before drugs go to the Food and Drug Administration for approval….
In the absence of a treatment for Alzheimer’s disease, researchers are turning to out-of-the-box approaches to slow or ease the progression of the disease….